Literature DB >> 24036014

Circulating 25-hydroxyvitamin D serum concentration and total cancer incidence and mortality: a systematic review and meta-analysis.

Lu Yin1, José M Ordóñez-Mena, Tianhui Chen, Ben Schöttker, Volker Arndt, Hermann Brenner.   

Abstract

OBJECTIVE: To conduct a systematic review and meta-analysis of longitudinal studies on the association of 25(OH)D with total cancer incidence and mortality.
METHOD: Relevant longitudinal observational studies were identified by systematically searching Ovid Medline, EMBASE, and ISI Web of Knowledge databases. Due to the heterogeneity across studies in categorizing 25(OH)D concentration, all results were recalculated for an increase of 25(OH)D by 50 nmol/L.
RESULTS: In meta-analyses with random effects models, the summary risk ratios and confidence intervals (RRs (95% CI)) for the association of an increase of 25(OH)D by 50 nmol/L with total cancer incidence (5 studies) and mortality (13 studies) were 0.89 (0.81, 0.97) and 0.83 (0.71, 0.96), respectively. In sex-specific analyses no significant association with total cancer incidence was observed among men or women. A clear inverse association with total cancer mortality was observed among women (0.76 (0.60, 0.98)) but not among men (0.92 (0.65, 1.32)). Large heterogeneity was observed for studies on total cancer mortality (P<0.01) but not for studies on cancer incidence (P=0.41). No publication bias was found.
CONCLUSION: The meta-analysis suggests a moderate inverse association of 25(OH)D concentration with total cancer incidence and mortality.
© 2013.

Entities:  

Keywords:  Cancer; Incidence; Meta-Analysis; Mortality; Vitamin D

Mesh:

Substances:

Year:  2013        PMID: 24036014     DOI: 10.1016/j.ypmed.2013.08.026

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  45 in total

1.  Association Between Prediagnostic Serum 25-Hydroxyvitamin D Concentration and Glioma.

Authors:  Victoria Zigmont; Amy Garrett; Jin Peng; Michal Seweryn; Grzegorz A Rempala; Randall Harris; Christopher Holloman; Thomas E Gundersen; Anders Ahlbom; Maria Feychting; Tom Borge Johannesen; Tom Kristian Grimsrud; Judith Schwartzbaum
Journal:  Nutr Cancer       Date:  2015-08-28       Impact factor: 2.900

2.  Pre-diagnostic 25-hydroxyvitamin D levels and survival in cancer patients.

Authors:  Johanna E Torfadottir; Thor Aspelund; Unnur A Valdimarsdottir; Mary Frances Cotch; Laufey Tryggvadottir; Tamara B Harris; Vilmundur Gudnason; Hans-Olov Adami; Lorelei A Mucci; Edward L Giovannucci; Meir J Stampfer; Laufey Steingrimsdottir
Journal:  Cancer Causes Control       Date:  2019-02-25       Impact factor: 2.506

3.  Longitudinal associations between lifestyle and vitamin D: A general population study with repeated vitamin D measurements.

Authors:  Tea Skaaby; Lise Lotte Nystrup Husemoen; Betina Heinsbæk Thuesen; Charlotta Pisinger; Anke Hannemann; Torben Jørgensen; Allan Linneberg
Journal:  Endocrine       Date:  2015-05-30       Impact factor: 3.633

4.  Circulating 25-hydroxyvitamin D up to 3 decades prior to diagnosis in relation to overall and organ-specific cancer survival.

Authors:  Stephanie J Weinstein; Alison M Mondul; Kai Yu; Tracy M Layne; Christian C Abnet; Neal D Freedman; Racheal Z Stolzenberg-Solomon; Unhee Lim; Mitchell H Gail; Demetrius Albanes
Journal:  Eur J Epidemiol       Date:  2018-08-02       Impact factor: 8.082

5.  Pre-diagnostic vitamin D concentrations and cancer risks in older individuals: an analysis of cohorts participating in the CHANCES consortium.

Authors:  José Manuel Ordóñez-Mena; Ben Schöttker; Veronika Fedirko; Mazda Jenab; Anja Olsen; Jytte Halkjær; Ellen Kampman; Lisette de Groot; Eugene Jansen; H Bas Bueno-de-Mesquita; Petra H Peeters; Galatios Siganos; Tom Wilsgaard; Laura Perna; Bernd Holleczek; Ulrika Pettersson-Kymmer; Philippos Orfanos; Antonia Trichopoulou; Paolo Boffetta; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2015-05-15       Impact factor: 8.082

6.  Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis.

Authors:  Yonghua Xu; Xiaoping Shao; Yacheng Yao; Lijian Xu; Liang Chang; Zhuojuan Jiang; Zhaofen Lin
Journal:  J Cancer Res Clin Oncol       Date:  2014-05-17       Impact factor: 4.553

7.  Vitamin D Supplements and Prevention of Cancer and Cardiovascular Disease.

Authors:  JoAnn E Manson; Nancy R Cook; I-Min Lee; William Christen; Shari S Bassuk; Samia Mora; Heike Gibson; David Gordon; Trisha Copeland; Denise D'Agostino; Georgina Friedenberg; Claire Ridge; Vadim Bubes; Edward L Giovannucci; Walter C Willett; Julie E Buring
Journal:  N Engl J Med       Date:  2018-11-10       Impact factor: 91.245

8.  Vitamin D derivatives enhance cytotoxic effects of H2O2 or cisplatin on human keratinocytes.

Authors:  Anna Piotrowska; Justyna Wierzbicka; Tomasz Ślebioda; Michał Woźniak; Robert C Tuckey; Andrzej T Slominski; Michał A Żmijewski
Journal:  Steroids       Date:  2016-04-13       Impact factor: 2.668

9.  Principal results of the VITamin D and OmegA-3 TriaL (VITAL) and updated meta-analyses of relevant vitamin D trials.

Authors:  JoAnn E Manson; Shari S Bassuk; Julie E Buring
Journal:  J Steroid Biochem Mol Biol       Date:  2019-11-13       Impact factor: 4.292

10.  Association between Vitamin D Deficiency and Antinuclear Antibodies in Middle-Aged and Older U.S. Adults.

Authors:  Helen C S Meier; Dale P Sandler; Eleanor M Simonsick; Christine G Parks
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-08-19       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.